Table 1.

Summary of MA, HLA-identical HSCT for SCD.

Ref.	n, age range (years)	Graft failure	Acute GVHD, Grade II-IV	Chronic GVHD	Overall survival	Disease-free survival
Walters et al[10]	n=22 3-14	18%	9%	4.5%	91% at 4 years	73% at 4 years
Panepinto et al** [11]	n=67	13.4%	10%	22%	97% at 5 years	85% at 5 years
Bernaudin et al [12]	n=87 2-22	22.6%/ 3%*	20%	12.6%	93.1% at 6 years	86.1% at 6 years
Dedeken et al [13]	n=50 1-15	8%	22%	20%	94.1% at 8 years	85.6% at 8 years
García-Morin et al[14]	n=11 2-13	18%	55%	0%	90.9% at 3 years	81.9% at 3 years
Dallas et al (MRD cohort) [15]	n=14 5-17	0%	28%	21%	93% at 9 years	93% at 9 years

^*Graft failure was 22% in patients who did not receive ATG during conditioning, and 3% in patients who received ATG during conditioning.

^**Study included an unknown number of patients reported in Walters et al (1996).